Vektor Pharma TF GmbH distributes the COVID-ID lab 25 minutes rapid PCR test and supports the development of new biosensors. The company develops transdermal formulations and other drug loaded films. Vektor combines profound knowledge in pharmaceutical development and production with the art of engineering. Contract development projects include both, NCEs as well as generic drugs. New technologies are applied for development production, which allow easy scale-up and fast change times. In addition, the company offers own develoment projects, which are offered also for public investments. Vektor Pharma TF serves clients and partners from many countries worldwide.